AbbVie Inc. (ABBV) Technical Indicators Remain Partialy Favorable

Marco Green
October 13, 2017

Dumont & Blake Investment Advisors Llc who had been investing in Abbvie Inc (Call) for a number of months, seems to be less bullish one the $146.40B market cap company. Corporate insiders own 0.23% of the company's stock. It now has negative earnings.

This stock (ABBV) is ahead of its 52-week low with 67.77%. Investec Asset Management LTD now owns 166,978 shares of the company's stock valued at $10,880,000 after acquiring an additional 5,801 shares during the last quarter. The Apriem Advisors holds 88,961 shares with $6.45 million value, down from 94,667 last quarter.

Waking on tracing line of previous stocks, New Oriental Education & Technology Group Inc. At Bancshares holds 26,222 shares or 0.22% of its portfolio. About 245,985 shares traded. It is down 10.63% since October 12, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

In a report revealed on Wednesday, 11 October, Cowen \u0026 Co. announced that they have made a decision to upgrade shares of AbbVie (NYSE:ABBV) stock from a Market Perform to a Outperform. Staley Advisers stated it has 13,010 shares or 0.08% of all its holdings.

Ballentine Partners Llc decreased Vanguard Index Fds (VOO) stake by 2,405 shares to 10,410 valued at $2.37 million in 2017Q2.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 48% are positive. Equities research analysts expect that AbbVie Inc. will post $5.53 EPS for the current year. As per Friday, September 2, the company rating was initiated by Raymond James. The company was maintained on Sunday, July 30 by BMO Capital Markets. Morgan Stanley downgraded the shares of ABBV in report on Wednesday, June 8 to "Equal-Weight" rating. The stock of AbbVie Inc (NYSE:ABBV) has "Buy" rating given on Monday, May 29 by Jefferies. The firm has "Hold" rating given on Friday, April 28 by BMO Capital Markets. Credit Suisse maintained the stock with "Hold" rating in Wednesday, June 7 report.

AbbVie Inc. value Change from Open was at 1.05% with a Gap of 0.41%. Goldman Sachs downgraded AbbVie Inc (NYSE:ABBV) on Monday, March 7 to "Buy" rating. Deutsche Bank upgraded AbbVie Inc (NYSE:ABBV) rating on Thursday, September 28. Jefferies maintained the stock with "Buy" rating in Thursday, May 25 report.

A statistical measure of the dispersion of returns (volatility) for ABBV producing salvation in Investors mouth, it has week volatility of 1.48% and for the month booked as 1.94%. Its down 0.39, from 1.3 in 2017Q1.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. 138 funds opened positions while 500 raised stakes. Zwj Inv Counsel accumulated 33,541 shares. Janney Montgomery Scott Limited Liability Co owns 0% invested in FMC Corp (NYSE:FMC) for 3,559 shares. Lsv Asset Mngmt accumulated 6.63 million shares. Zacks Inv Mngmt holds 1.03% or 574,748 shares.

Hodges Capital Management Inc. holds 2.21% of its portfolio in J C Penney Company Inc for 8.01 million shares. Guinness Atkinson Asset owns 3,480 shares or 0.16% of their United States portfolio. Cypress Capital Mgmt Ltd Company (Wy), Wyoming-based fund reported 3,335 shares. Profund Advsrs Lc holds 19,472 shares or 0.01% of its portfolio. Lazard Asset Ltd holds 0.05% or 329,140 shares. Monarch Management stated it has 72,718 shares. Heartland holds 446,603 shares or 0.44% of its portfolio. Public Sector Pension Investment Board has invested 0.11% in AbbVie Inc (NYSE:ABBV). Private Wealth Prns Ltd Co reported 0.12% stake. Campbell Newman Asset invested 0.33% of its portfolio in AbbVie Inc (NYSE:ABBV). Stifel Financial Corp owns 2.89 million shares. It also reduced Hrdg Lvnr Intl Equity stake by 40,715 shares and now owns 149,685 shares. American Express Co (NYSE:AXP) was raised too.

Since May 4, 2017, it had 0 buys, and 5 sales for $18.84 million activity. $5.59 million worth of AbbVie Inc (NYSE:ABBV) was sold by Schumacher Laura J. GONZALEZ RICHARD A sold $4.67M worth of stock. $2.50 million worth of AbbVie Inc (NYSE:ABBV) shares were sold by CHASE WILLIAM J.

ABBV's average Beneish M-Score: -2.51 during the last 7 years. It has outperformed by 2.22% the S&P500.

Ratings analysis reveals 100% of Eldorado Resorts's analysts are positive. More interesting news about AbbVie Inc (NYSE:ABBV) were released by: Fool.com and their article: "AbbVie's Fast Becoming a Top Stock to Buy Now" published on October 08, 2017 as well as Nasdaq.com's news article titled: "AbbVie Reaches Analyst Target Price" with publication date: October 12, 2017. ERI was included in 2 notes of analysts from August 19, 2016.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER